Follow
Antonello Pietrangelo
Antonello Pietrangelo
Verified email at unimore.it
Title
Cited by
Cited by
Year
Hereditary hemochromatosis—a new look at an old disease
A Pietrangelo
New England Journal of Medicine 350 (23), 2383-2397, 2004
12922004
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ...
The Lancet Rheumatology 2 (8), e474-e484, 2020
10292020
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
B Andriopoulos Jr, E Corradini, Y Xia, SA Faasse, S Chen, L Grgurevic, ...
Nature genetics 41 (4), 482-487, 2009
9362009
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
S De Biasi, M Meschiari, L Gibellini, C Bellinazzi, R Borella, L Fidanza, ...
Nature communications 11 (1), 3434, 2020
7432020
Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment
A Pietrangelo
Gastroenterology 139 (2), 393-408. e2, 2010
7182010
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
G Montosi, A Donovan, A Totaro, C Garuti, E Pignatti, S Cassanelli, ...
The Journal of clinical investigation 108 (4), 619-623, 2001
6912001
EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
TE Jury
Journal of Hepatology 39, 3-25, 2003
5632003
EASL clinical practice guidelines for HFE hemochromatosis
European Association For The Study Of The Liver
Journal of hepatology 53 (1), 3-22, 2010
533*2010
The ferroportin disease
A Pietrangelo
Blood Cells, Molecules, and Diseases 32 (1), 131-138, 2004
4772004
ER stress controls iron metabolism through induction of hepcidin
C Vecchi, G Montosi, K Zhang, I Lamberti, SA Duncan, RJ Kaufman, ...
Science 325 (5942), 877-880, 2009
3842009
STAT3 is required for IL-6-gp130–dependent activation of hepcidin in vivo
A Pietrangelo, U Dierssen, L Valli, C Garuti, A Rump, E Corradini, M Ernst, ...
Gastroenterology 132 (1), 294-300, 2007
3802007
Iron regulatory proteins in pathobiology
G CAIRO, A Pietrangelo
Biochemical Journal 352 (2), 241-250, 2000
3782000
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload
H Zoller, G Weiss, I Theurl, RO Koch, W Vogel, P Obrist, A Pietrangelo, ...
Gastroenterology 120 (6), 1412-1419, 2001
3682001
Haemochromatosis
P Brissot, A Pietrangelo, PC Adams, B De Graaff, CE McLaren, O Loréal
Nature reviews Disease primers 4 (1), 1-15, 2018
3462018
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene
A Pietrangelo, G Montosi, A Totaro, C Garuti, D Conte, S Cassanelli, ...
New England Journal of Medicine 341 (10), 725-732, 1999
3431999
Hepatitis C virus–induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription
S Nishina, K Hino, M Korenaga, C Vecchi, A Pietrangelo, Y Mizukami, ...
Gastroenterology 134 (1), 226-238, 2008
3112008
Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells
P Schirmacher, A Geerts, A Pietrangelo, HP Dienes, CE Rogler
Hepatology 15 (1), 5-11, 1992
2961992
Heterogeneity of hemochromatosis in Italy
A Piperno, M Sampietro, A Pietrangelo, C Arosio, L Lupica, G Montosi, ...
Gastroenterology 114 (5), 996-1002, 1998
2921998
Non‐HFE hemochromatosis
A Pietrangelo
Hepatology 39 (1), 21-29, 2004
2542004
Hemochromatosis: an endocrine liver disease
A Pietrangelo
Hepatology 46 (4), 1291-1301, 2007
2512007
The system can't perform the operation now. Try again later.
Articles 1–20